Cargando…

Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status

BACKGROUND: Several researchers have claimed that classification of tumours on the basis of HER-2/neu overexpression or amplification may define a subset of breast cancer in which the net effect of a risk factor could be rather more obvious and its impact on breast cancer development more clear. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsakountakis, Nikos, Sanidas, Elias, Stathopoulos, Efstathios, Kafousi, Maria, Anogiannaki, Nektaria, Georgoulias, Vasilis, Tsiftsis, Dimitris D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549187/
https://www.ncbi.nlm.nih.gov/pubmed/15694000
http://dx.doi.org/10.1186/1472-6874-5-1
_version_ 1782122398886133760
author Tsakountakis, Nikos
Sanidas, Elias
Stathopoulos, Efstathios
Kafousi, Maria
Anogiannaki, Nektaria
Georgoulias, Vasilis
Tsiftsis, Dimitris D
author_facet Tsakountakis, Nikos
Sanidas, Elias
Stathopoulos, Efstathios
Kafousi, Maria
Anogiannaki, Nektaria
Georgoulias, Vasilis
Tsiftsis, Dimitris D
author_sort Tsakountakis, Nikos
collection PubMed
description BACKGROUND: Several researchers have claimed that classification of tumours on the basis of HER-2/neu overexpression or amplification may define a subset of breast cancer in which the net effect of a risk factor could be rather more obvious and its impact on breast cancer development more clear. We decided to investigate, in a group of patients from a geographical area with a low incidence of breast cancer, whether HER-2/neu positive tumours are correlated with established or suspected risk factors for breast cancer and thus to identify distinct subgroups of high risk women. METHODS: This study analysed data from patients who attended the Breast Unit at the University Hospital of Heraklion, Crete, Greece between 1996 and 2002. 384 women with primary invasive breast cancer were compared with 566 screened women who were referred to the Unit and had not developed breast neoplasm by the time the data were analysed. Risk factor data were obtained from each subject by personal interviews using a structured questionnaire. The detection and scoring of the HER-2/neu protein, estrogen and progesterone receptor expression were performed using immunochemistry. Odds ratios and 95% confidence intervals were determined by chi-square test and logistic regression analysis. Case-case odds ratios were calculated in order to measure the risk heterogeneity between HER-2/neu+ and HER-2/neu-tumours. Separate analyses were performed for premenopausal and postmenopausal women and according to estrogen receptor status. RESULTS: In multivariate analysis without HER-2/neu stratification, an increased breast cancer risk was associated with only four of the factors examined: use of oral contraceptives (OR = 4.40, 95%C.I: 1.46–13.28), use of HRT (OR = 7.34, 95%C.I: 2.03–26.53), an age at first full pregnancy more than 23 years (OR = 1.91, 95%C.I: 1.29–2.83) and body mass index more than 29 kg/m(2 )(OR = 3.13, 95%C.I: 2.02–4.84). Additionally, a history of abortion or miscarriage (OR = 0.56, 95%C.I: 0.38–0.82) was correlated with a decreased risk of breast cancer. In the case to case comparison only BMI >29 kg/m(2 )revealed a relative connection that was stronger with positive than with negative HER-2/neu tumours (ratio of OR's = 2.23, 95%C.I: 1.20–4.15, p = 0.011). This may indicate evidence of heterogeneity of a rather significant degree for this factor. In the ER negative group an age at first full pregnancy >23 years and a BMI >29 kg/m(2 )were associated with an increased risk in both HER-2/neu groups, but the association was significantly stronger for the latter factor in the positive HER-2/neu tumours (ratio of OR's = 2.46, 95%CI: 0.97–6.21). CONCLUSIONS: Our study did not confirm that the established or putative hormonal breast cancer risk factors differ regarding their relations with HER-2/neu+ versus HER-2/neu-breast tumours, with the exception of increased BMI. Further innovative studies with larger sample sizes are needed to examine how the status of these potentially modifiable breast cancer risk factors interacts with biological markers such as HER-2/neu oncoprotein.
format Text
id pubmed-549187
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5491872005-02-20 Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status Tsakountakis, Nikos Sanidas, Elias Stathopoulos, Efstathios Kafousi, Maria Anogiannaki, Nektaria Georgoulias, Vasilis Tsiftsis, Dimitris D BMC Womens Health Research Article BACKGROUND: Several researchers have claimed that classification of tumours on the basis of HER-2/neu overexpression or amplification may define a subset of breast cancer in which the net effect of a risk factor could be rather more obvious and its impact on breast cancer development more clear. We decided to investigate, in a group of patients from a geographical area with a low incidence of breast cancer, whether HER-2/neu positive tumours are correlated with established or suspected risk factors for breast cancer and thus to identify distinct subgroups of high risk women. METHODS: This study analysed data from patients who attended the Breast Unit at the University Hospital of Heraklion, Crete, Greece between 1996 and 2002. 384 women with primary invasive breast cancer were compared with 566 screened women who were referred to the Unit and had not developed breast neoplasm by the time the data were analysed. Risk factor data were obtained from each subject by personal interviews using a structured questionnaire. The detection and scoring of the HER-2/neu protein, estrogen and progesterone receptor expression were performed using immunochemistry. Odds ratios and 95% confidence intervals were determined by chi-square test and logistic regression analysis. Case-case odds ratios were calculated in order to measure the risk heterogeneity between HER-2/neu+ and HER-2/neu-tumours. Separate analyses were performed for premenopausal and postmenopausal women and according to estrogen receptor status. RESULTS: In multivariate analysis without HER-2/neu stratification, an increased breast cancer risk was associated with only four of the factors examined: use of oral contraceptives (OR = 4.40, 95%C.I: 1.46–13.28), use of HRT (OR = 7.34, 95%C.I: 2.03–26.53), an age at first full pregnancy more than 23 years (OR = 1.91, 95%C.I: 1.29–2.83) and body mass index more than 29 kg/m(2 )(OR = 3.13, 95%C.I: 2.02–4.84). Additionally, a history of abortion or miscarriage (OR = 0.56, 95%C.I: 0.38–0.82) was correlated with a decreased risk of breast cancer. In the case to case comparison only BMI >29 kg/m(2 )revealed a relative connection that was stronger with positive than with negative HER-2/neu tumours (ratio of OR's = 2.23, 95%C.I: 1.20–4.15, p = 0.011). This may indicate evidence of heterogeneity of a rather significant degree for this factor. In the ER negative group an age at first full pregnancy >23 years and a BMI >29 kg/m(2 )were associated with an increased risk in both HER-2/neu groups, but the association was significantly stronger for the latter factor in the positive HER-2/neu tumours (ratio of OR's = 2.46, 95%CI: 0.97–6.21). CONCLUSIONS: Our study did not confirm that the established or putative hormonal breast cancer risk factors differ regarding their relations with HER-2/neu+ versus HER-2/neu-breast tumours, with the exception of increased BMI. Further innovative studies with larger sample sizes are needed to examine how the status of these potentially modifiable breast cancer risk factors interacts with biological markers such as HER-2/neu oncoprotein. BioMed Central 2005-02-04 /pmc/articles/PMC549187/ /pubmed/15694000 http://dx.doi.org/10.1186/1472-6874-5-1 Text en Copyright © 2005 Tsakountakis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tsakountakis, Nikos
Sanidas, Elias
Stathopoulos, Efstathios
Kafousi, Maria
Anogiannaki, Nektaria
Georgoulias, Vasilis
Tsiftsis, Dimitris D
Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
title Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
title_full Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
title_fullStr Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
title_full_unstemmed Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
title_short Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status
title_sort correlation of breast cancer risk factors with her-2/neu protein overexpression according to menopausal and estrogen receptor status
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549187/
https://www.ncbi.nlm.nih.gov/pubmed/15694000
http://dx.doi.org/10.1186/1472-6874-5-1
work_keys_str_mv AT tsakountakisnikos correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus
AT sanidaselias correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus
AT stathopoulosefstathios correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus
AT kafousimaria correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus
AT anogiannakinektaria correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus
AT georgouliasvasilis correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus
AT tsiftsisdimitrisd correlationofbreastcancerriskfactorswithher2neuproteinoverexpressionaccordingtomenopausalandestrogenreceptorstatus